Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Introduction to Documentation and Reporting

Introduction to Documentation and Reporting

Documentation is the systematic process of formally recording, maintaining, and communicating information.
Nursing documentation records essential information and details regarding a patient's care and treatment in written or electronic form. It is a critical aspect of nursing practice that involves documenting assessments, interventions, outcomes, and other relevant details about a patient's health status.
Documentation maps the patient's health journey by creating a comprehensive and precise...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

In Vitro Drug Release Testing: Overview, Development and Validation

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Regulatory and Ethical Frameworks for First-in-Human Clinical Trials in India: Proceedings of a Codesigned Capacity-Building Workshop.

Clinical drug investigation·2026

Same author

Systematic analyses of lipid mobilization by human lipid transfer proteins.

Nature·2026

Same author

A tale of two APIC chapters: A pilot study measuring burnout in infection preventionists using the Maslach Burnout Inventory (MBI).

American journal of infection control·2025

Same author

Regulatory Issues of Platform Trials: Learnings from EU-PEARL.

Clinical pharmacology and therapeutics·2024

Same author

Developing generic templates to shape the future for conducting integrated research platform trials.

Trials·2024

Same author

The sustained usefulness of online learning to educate nurses about antibiotic stewardship.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2024

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Optimizing Clinical Study Report Development Through Lean Authoring: A Framework for Meeting Regulatory Expectations

Lauren Geary¹, Inger Ødum Nielsen², Fiona Charron³

¹Eli Lilly and Company, 893 S Delaware St, Indianapolis, IN, 46225, USA. lgeary@lilly.com.

Therapeutic Innovation & Regulatory Science

|June 10, 2026

Summary

Lean authoring improves pharmaceutical document creation by focusing on clear, concise content for regulatory reviewers. This approach enhances efficiency, reduces review times, and ensures better quality clinical study reports (CSRs).

Keywords:

Automation Clinical documents Clinical study reports (CSRs)Digital transformation Lean authoring Regulatory documents

Related Experiment Videos

Last Updated: Jun 12, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

Area of Science:

Pharmaceutical industry
Medical writing
Regulatory affairs

Background:

Efficient creation of clinical documents like clinical study reports (CSRs) is crucial in the pharmaceutical industry.
Current document creation processes can be inefficient and lead to lengthy regulatory reviews.
Medical writing leaders advocate for improved authoring methodologies.

Purpose of the Study:

To provide a comprehensive overview of lean authoring in the pharmaceutical sector.
To emphasize the importance of lean authoring for efficient CSR and clinical document creation.
To outline a step-by-step approach for adopting lean authoring methods and managing change.

Main Methods:

Review of experiences from medical writing leaders in the pharmaceutical industry.
Definition and explanation of lean authoring principles and their application.
Discussion of strategies to overcome implementation challenges, including resistance to change.

Main Results:

Lean authoring delivers unambiguous, clear, concise, and objective content tailored to regulatory reviewer needs.
Benefits include improved readability, content reusability, enhanced efficiency, cost-effectiveness, and more efficient regulatory reviews.
Adoption of lean authoring can lead to fewer review questions and reduced burden on reviewers.

Conclusions:

Lean authoring optimizes the document creation process in the pharmaceutical industry.
It improves the quality of CSRs and increases the efficiency of regulatory reviews.
Adopting lean authoring aligns with healthcare agency preferences for clear and concise information.